Skip to main content
SpringerLink
Log in

RCT data not to be RE-LYed on, `real-world' NOAC users older

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Randomized Evaluation of Long-Term Anticoagulation Therapy

References

  1. Xu Y, et al. Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis. CMAJ Open 1: E115-E119, No. 3, 16 Oct 2013. Available from: URL: http://dx.doi.org/10.9778/cmajo.20130032

    Google Scholar 

  2. Coppens M, et al. Stroke prevention in older adults with atrial fibrillation. Canadian Medical Association Journal : [2 pages], 16 Oct 2013. Available from: URL: http://dx.doi.org/10.1503/cmaj.131291

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

RCT data not to be RE-LYed on, `real-world' NOAC users older. PharmacoEcon Outcomes News 690, 6 (2013). https://doi.org/10.1007/s40274-013-0826-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0826-3

Search

Navigation